Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Petroleum | ATLADKK | Jun 14, 2024 | 2.68 | +1.13 |
Audientes | AUDNTS | Jun 14, 2024 | 0.04 | -1.01 |
Bactiquant | BACTIQ | Jun 14, 2024 | 9.75 | +10.80 |
Bang & Olufsen | BO | Jun 14, 2024 | 9.72 | -0.61 |
BankNordik P/F | BNORDIKCSE | Jun 14, 2024 | 151.00 | -0.33 |
Bavarian Nordic | BAVA | Jun 14, 2024 | 162.50 | -2.49 |
Better Collective A/S | BETCODKK | Jun 14, 2024 | 146.00 | -3.18 |
BioPorto | BIOPOR | Jun 14, 2024 | 1.67 | -0.83 |
Boozt | BOOZTDKK | Jun 14, 2024 | 83.95 | -3.95 |
Brain+ | BRAINP | Jun 14, 2024 | 0.07 | -6.42 |
Brd. Klee B | KLEEB | Jun 14, 2024 | 3 940.00 | 0.00 |
Brdr. A & O Johansen Pref B | AOJB | Jun 14, 2024 | 72.90 | -2.15 |
Brøndbyernes IF Fodbold | BIF | Jun 14, 2024 | 0.62 | -0.32 |
Carlsberg A | CARLA | Jun 14, 2024 | 1 100.00 | -0.90 |
Carlsberg B | CARLB | Jun 14, 2024 | 938.20 | -0.97 |
cBrain | CBRAIN | Jun 14, 2024 | 248.50 | -2.17 |
Cemat | CEMAT | Jun 14, 2024 | 0.89 | -3.46 |
Cessatech A/S | CEASES | Jun 14, 2024 | 6.06 | 0.00 |
ChemoMetec | CHEMM | Jun 14, 2024 | 315.20 | -1.07 |
Coloplast B | COLOB | Jun 14, 2024 | 851.60 | -0.30 |
Columbus | COLUM | Jun 14, 2024 | 9.60 | -0.21 |
Conferize | CONFRZ | Jun 14, 2024 | 0.02 | -3.13 |
Copenhagen Capital | CPHCAPST | Jun 14, 2024 | 5.25 | +2.94 |
Copenhagen Capital 40 pct Pref 2032 | CPHCAPPREF32 | Jun 14, 2024 | 8.10 | 0.00 |
CS Medica | CSMED | Jun 14, 2024 | 3.55 | +4.41 |
D/S Norden | DNORD | Jun 14, 2024 | 292.40 | -2.73 |
DanCann Pharma A/S | DANCE | Jun 14, 2024 | 0.03 | 0.00 |
Danish Aerospace Company | DAC | Jun 14, 2024 | 3.06 | +0.66 |
Danske Andelskassers Bank | DAB | Jun 14, 2024 | 11.70 | -0.85 |
Danske Bank | DANSKE | Jun 14, 2024 | 202.40 | -1.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.